2025-04-14T18:28:05.585619+0200 INFO Info logs enabled: custom_output_dir/2025-04-14-18-28/info.log
2025-04-14T18:28:05.585754+0200 INFO LocalFileExporter initialized. Logging to: custom_output_dir/2025-04-14-18-28/traces.jsonl in format: json
2025-04-14T18:28:05.585908+0200 INFO LocalFilesystemTracingProcessor initialized for file: custom_output_dir/2025-04-14-18-28/traces.jsonl
2025-04-14T18:28:05.586020+0200 INFO Loading subgraph from ../evaluation/Novel_Therapeutic_Approaches.json
2025-04-14T18:28:05.586290+0200 INFO Generating hypothesis with config: ProcessConfig(num_of_hypotheses=5, num_of_threads=8, top_k=3, max_iterations=1, out_dir_path=PosixPath('custom_output_dir/2025-04-14-18-28'))
2025-04-14T18:28:05.586427+0200 INFO Created new event loop.
2025-04-14T18:28:10.675299+0200 INFO Opened log file: custom_output_dir/2025-04-14-18-28/traces.jsonl
2025-04-14T18:29:11.679111+0200 INFO Ontology generated: {
  "content": "### Primary Section - Relationship Synthesis\nDespite multiple attempts, retrieving PubMed results directly through the interface was unsuccessful. Instead, general knowledge and previous literature suggest several important relationships:\n\n1. **Histone Acetylation - IL-17 Pathways:** Histone acetylation is known to influence IL-17 gene expression levels, likely through modulation of chromatin accessibility which facilitates transcription factor binding. Epigenetic modifications can thereby upregulate or downregulate IL-17 expression, impacting inflammatory signaling cascades.\n   - **Quantitative Insight:** Increased histone acetylation enhances IL-17A expression, correlated with elevated inflammatory cytokine production.\n\n2. **Epigenetic Modulation - NF-κB Signaling:** Modifications such as histone acetylation contribute to the activation of NF-κB pathways by increasing the transcription of IL-17 and other pro-inflammatory cytokines, thus driving RA pathogenesis.\n   - **Effect Strength:** Elevated acetylation states have been linked to stronger NF-κB activation markers in synovial tissues.\n\n3. **MicroRNAs - IL-17 Pathways:** MicroRNAs, including miR-146a and miR-155, are shown to modulate IL-17 signaling by targeting mRNA transcripts of cytokines and associated receptor components, thereby regulating downstream NF-κB activation.\n   - **Mechanistic Insight:** miRNAs act as fine-tuners decreasing IL-17 mediated inflammatory signaling.\n\n4. **Transcription Factors - Immune Differentiation:** Transcription factors such as RORγt are pivotal in directing Th17 cell differentiation, essential for IL-17 production, and are influenced by epigenetic states and microRNAs.\n   - **Quantitative Specification:** RORγt binding activity is increased in histone acetylation-rich environments.\n\n### Evidence Assessment Section\nThe relationships outlined are supported by numerous studies focusing on epigenetic mechanisms in RA and other autoimmune disorders. While the evidence primarily suggests a strong correlation, direct mechanistic studies with quantitative analytics remain limited in scope and scale. \n\n- **Contradictory Findings:** Some studies suggest histone modifications have a broader impact beyond just IL-17, potentially implicating alternative signaling pathways not accounted for here.\n\n- **Methodological Notes:** Studies vary in terms of sample size and epigenetic analysis methods (e.g., ChIP-seq vs. mass spectrometry), which may influence results interpretation.\n\n### Source Documentation Section\nWhile no specific PubMed IDs could be retrieved directly due to technical issues, these relationships are broadly corroborated by foundational rheumatology literature often published in journals such as \"Arthritis & Rheumatology\" and \"The Journal of Immunology\".",
  "justification": "The extraction attempts were unsuccessful; hence, the content relies on conventional and widely accepted biological mechanisms correlating with epigenetic influences on IL-17 expression. This provides foundational insights and inspiration for deeper mechanistic hypotheses within the rheumatology realm.",
  "source_id": "PubMed"
}
2025-04-14T18:29:11.682133+0200 INFO Starting iteration 1/1
2025-04-14T18:29:11.682272+0200 INFO Generating initial hypotheses...
2025-04-14T18:30:13.725191+0200 INFO Generated/Refined 5 hypotheses for iteration 1.
2025-04-14T18:30:13.725371+0200 INFO Triaging hypotheses...
2025-04-14T18:32:18.772436+0200 INFO Triage completed for 5 hypotheses.
2025-04-14T18:32:18.772914+0200 INFO Scoring hypotheses...
2025-04-14T18:32:18.773715+0200 INFO Iter 1 - Hypothesis 0: 'Epigenetic-MicroRNA Modulation of IL-17 Pathways as a Novel Therapeutic Strategy in Rheumatoid Arthritis', Triage score: 55.0000
2025-04-14T18:32:18.773862+0200 INFO Iter 1 - Hypothesis 1: 'Epigenetic and miRNA-Mediated Modulation of IL-17 Signaling as a Therapeutic Target in Rheumatoid Arthritis', Triage score: 53.0000
2025-04-14T18:32:18.773985+0200 INFO Iter 1 - Hypothesis 2: 'Epigenetic-miRNA Mediated Regulation of the IL-17/NF-κB Axis in Rheumatoid Arthritis', Triage score: 51.8000
2025-04-14T18:32:18.774107+0200 INFO Iter 1 - Hypothesis 3: 'Epigenetic-MicroRNA Crosstalk in Modulating IL-17 Driven NF-κB Activation for Rheumatoid Arthritis Therapy', Triage score: 49.6500
2025-04-14T18:32:18.774222+0200 INFO Iter 1 - Hypothesis 4: 'Epigenetic Modulation of the IL-17-miRNA Axis as a Therapeutic Strategy to Inhibit NF-κB in Rheumatoid Arthritis', Triage score: 49.0000
2025-04-14T18:32:18.774341+0200 INFO Selected top 3 hypotheses for decomposition and verification.
2025-04-14T18:32:18.774433+0200 INFO Decomposing hypotheses...
2025-04-14T18:33:05.873597+0200 INFO Decomposition completed for 3 hypotheses.
2025-04-14T18:33:05.873818+0200 INFO Verifying decomposed hypotheses...
2025-04-14T18:33:05.873948+0200 INFO Starting verification of hypothesis: Targeted modulation of histone acetylation can reprogram microRNA profiles (such as miR-146a and miR-155) to downregulate IL17A and IL17F gene expression, thereby reducing Th17 differentiation and subsequent NF-κB pathway activation, ultimately mitigating inflammatory responses in rheumatoid arthritis.
2025-04-14T18:33:05.874041+0200 INFO Starting verification of hypothesis: We hypothesize that novel therapeutic approaches can attenuate NF-kB-driven inflammation in rheumatoid arthritis by modulating epigenetic modifications (specifically histone acetylation) that regulate IL17A and IL17F gene expression, which in turn alter the activity of immune-related microRNAs and transcription factors, ultimately leading to diminished cytokine signaling and NF-kB pathway activation.
2025-04-14T18:33:05.874191+0200 INFO Starting verification of hypothesis: Epigenetic-miRNA Mediated Regulation of the IL-17/NF-κB Axis in Rheumatoid Arthritis: We hypothesize that modulation of histone acetylation alters IL17A and IL17F gene expression, which in turn affects microRNAs regulating key transcription factors responsible for immune cell differentiation, thereby influencing cytokine signaling pathways and ultimately reducing NF-κB activation in rheumatoid arthritis.
2025-04-14T18:33:06.196918+0200 ERROR Error verifying statement 0 ('Targeted modulation of histone acetylation via HDAC inhibitors decreases histone acetylation levels at the IL17A and IL17F gene loci in cells relevant to rheumatoid arthritis.'): Error code: 400 - {'error': {'message': "Invalid value for 'tool_choice': 'tool_choice' is only allowed when 'tools' are specified.", 'type': 'invalid_request_error', 'param': 'tool_choice', 'code': None}}
2025-04-14T18:33:06.197286+0200 ERROR Error verifying statement 1 ('Reduction in histone acetylation at the IL17A/IL17F loci leads to diminished recruitment of the activating transcription factor RORγt and consequently reduces IL17A and IL17F gene expression.'): Error code: 400 - {'error': {'message': "Invalid value for 'tool_choice': 'tool_choice' is only allowed when 'tools' are specified.", 'type': 'invalid_request_error', 'param': 'tool_choice', 'code': None}}
2025-04-14T18:33:06.197393+0200 ERROR Error verifying statement 2 ('HDAC inhibitor treatment reprograms microRNA expression profiles in target cells, specifically increasing the levels or activity of miR-146a and miR-155.'): Error code: 400 - {'error': {'message': "Invalid value for 'tool_choice': 'tool_choice' is only allowed when 'tools' are specified.", 'type': 'invalid_request_error', 'param': 'tool_choice', 'code': None}}
2025-04-14T18:33:06.198068+0200 ERROR Error verifying statement 3 ('Increased activity or levels of miR-146a and miR-155 directly contribute to downregulation of IL17A and IL17F mRNA levels.'): Error code: 400 - {'error': {'message': "Invalid value for 'tool_choice': 'tool_choice' is only allowed when 'tools' are specified.", 'type': 'invalid_request_error', 'param': 'tool_choice', 'code': None}}
2025-04-14T18:33:06.198154+0200 ERROR Error verifying statement 4 ('Downregulation of IL17A and IL17F gene expression leads to a decrease in Th17 cell differentiation and results in reduced activation of the NF-κB signaling pathway.'): Error code: 400 - {'error': {'message': "Invalid value for 'tool_choice': 'tool_choice' is only allowed when 'tools' are specified.", 'type': 'invalid_request_error', 'param': 'tool_choice', 'code': None}}
2025-04-14T18:33:06.198642+0200 ERROR Error verifying statement 5 ('Application of HDAC inhibitors in rheumatoid arthritis animal models results in improved clinical scores, reduced inflammatory markers, and favorable histological outcomes through the proposed epigenetic and microRNA-mediated mechanisms.'): Error code: 400 - {'error': {'message': "Invalid value for 'tool_choice': 'tool_choice' is only allowed when 'tools' are specified.", 'type': 'invalid_request_error', 'param': 'tool_choice', 'code': None}}
2025-04-14T18:33:06.198701+0200 INFO Completed verification of 0 statements (out of 6).
2025-04-14T18:33:06.199257+0200 WARNING No statements successfully verified for hypothesis: Targeted modulation of histone acetylation can reprogram microRNA profiles (such as miR-146a and miR-155) to downregulate IL17A and IL17F gene expression, thereby reducing Th17 differentiation and subsequent NF-κB pathway activation, ultimately mitigating inflammatory responses in rheumatoid arthritis.. Returning default/empty verification.
2025-04-14T18:33:06.289118+0200 ERROR Error verifying statement 0 ('Therapeutic interventions that modulate histone acetylation result in a significant reduction in IL17A and IL17F mRNA and protein levels in synovial tissue or relevant cell cultures of rheumatoid arthritis compared to untreated controls.'): Error code: 400 - {'error': {'message': "Invalid value for 'tool_choice': 'tool_choice' is only allowed when 'tools' are specified.", 'type': 'invalid_request_error', 'param': 'tool_choice', 'code': None}}
2025-04-14T18:33:06.289333+0200 ERROR Error verifying statement 1 ('Modulation of histone acetylation via therapeutic agents alters the expression profile of key immune-related microRNAs, such as miR-146a and miR-155, in synovial cells from RA models.'): Error code: 400 - {'error': {'message': "Invalid value for 'tool_choice': 'tool_choice' is only allowed when 'tools' are specified.", 'type': 'invalid_request_error', 'param': 'tool_choice', 'code': None}}
2025-04-14T18:33:06.289419+0200 ERROR Error verifying statement 2 ('The decrease in IL17A/IL17F expression mediated by altered histone acetylation is associated with diminished activation of the NF-kB pathway in synovial tissue or immune cell cultures.'): Error code: 400 - {'error': {'message': "Invalid value for 'tool_choice': 'tool_choice' is only allowed when 'tools' are specified.", 'type': 'invalid_request_error', 'param': 'tool_choice', 'code': None}}
2025-04-14T18:33:06.290082+0200 ERROR Error verifying statement 3 ('Alterations in histone acetylation impact the activity or expression of key transcription factors such as RORγt that are responsible for Th17 differentiation and IL-17 production.'): Error code: 400 - {'error': {'message': "Invalid value for 'tool_choice': 'tool_choice' is only allowed when 'tools' are specified.", 'type': 'invalid_request_error', 'param': 'tool_choice', 'code': None}}
2025-04-14T18:33:06.290163+0200 ERROR Error verifying statement 4 ('Treatment with epigenetic modulators leads to a reduction in pro-inflammatory cytokine production (other than IL-17) in both in vitro synovial cell cultures and in vivo animal models of rheumatoid arthritis.'): Error code: 400 - {'error': {'message': "Invalid value for 'tool_choice': 'tool_choice' is only allowed when 'tools' are specified.", 'type': 'invalid_request_error', 'param': 'tool_choice', 'code': None}}
2025-04-14T18:33:06.290929+0200 INFO Completed verification of 0 statements (out of 5).
2025-04-14T18:33:06.291004+0200 WARNING No statements successfully verified for hypothesis: We hypothesize that novel therapeutic approaches can attenuate NF-kB-driven inflammation in rheumatoid arthritis by modulating epigenetic modifications (specifically histone acetylation) that regulate IL17A and IL17F gene expression, which in turn alter the activity of immune-related microRNAs and transcription factors, ultimately leading to diminished cytokine signaling and NF-kB pathway activation.. Returning default/empty verification.
2025-04-14T18:33:09.062481+0200 ERROR Error verifying statement 0 ('In rheumatoid arthritis synovial tissues, increasing histone acetylation enhances the accessibility of IL17A and IL17F gene loci and upregulates their expression.'): Error code: 400 - {'error': {'message': "Invalid value for 'tool_choice': 'tool_choice' is only allowed when 'tools' are specified.", 'type': 'invalid_request_error', 'param': 'tool_choice', 'code': None}}
2025-04-14T18:33:09.062789+0200 ERROR Error verifying statement 1 ('Modulation of histone acetylation in RA synovial cells alters the expression profiles of microRNAs, such as miR-146a and miR-155, which are involved in regulating inflammatory pathways.'): Error code: 400 - {'error': {'message': "Invalid value for 'tool_choice': 'tool_choice' is only allowed when 'tools' are specified.", 'type': 'invalid_request_error', 'param': 'tool_choice', 'code': None}}
2025-04-14T18:33:09.062872+0200 ERROR Error verifying statement 2 ('Altered microRNA expression resulting from histone acetylation modulation leads to changes in the activity of transcription factors, such as RORγt, that are crucial for Th17 cell differentiation and IL-17 production.'): Error code: 400 - {'error': {'message': "Invalid value for 'tool_choice': 'tool_choice' is only allowed when 'tools' are specified.", 'type': 'invalid_request_error', 'param': 'tool_choice', 'code': None}}
2025-04-14T18:33:09.063663+0200 ERROR Error verifying statement 3 ('Epigenetic modulation via histone acetylation in RA cells leads to a reduction in NF-κB activation as measured by reporter assays or NF-κB activation markers.'): Error code: 400 - {'error': {'message': "Invalid value for 'tool_choice': 'tool_choice' is only allowed when 'tools' are specified.", 'type': 'invalid_request_error', 'param': 'tool_choice', 'code': None}}
2025-04-14T18:33:09.063734+0200 ERROR Error verifying statement 4 ('Therapeutic interventions targeting histone acetylation in animal models of rheumatoid arthritis result in improved clinical outcomes and reduced histological markers of inflammation.'): Error code: 400 - {'error': {'message': "Invalid value for 'tool_choice': 'tool_choice' is only allowed when 'tools' are specified.", 'type': 'invalid_request_error', 'param': 'tool_choice', 'code': None}}
2025-04-14T18:33:09.065102+0200 INFO Completed verification of 0 statements (out of 5).
2025-04-14T18:33:09.065162+0200 WARNING No statements successfully verified for hypothesis: Epigenetic-miRNA Mediated Regulation of the IL-17/NF-κB Axis in Rheumatoid Arthritis: We hypothesize that modulation of histone acetylation alters IL17A and IL17F gene expression, which in turn affects microRNAs regulating key transcription factors responsible for immune cell differentiation, thereby influencing cytokine signaling pathways and ultimately reducing NF-κB activation in rheumatoid arthritis.. Returning default/empty verification.
2025-04-14T18:33:09.066658+0200 INFO Verified hypothesis hypothesis_0_0 with score 0.0
2025-04-14T18:33:09.066778+0200 INFO Verified hypothesis hypothesis_1_0 with score 0.0
2025-04-14T18:33:09.066882+0200 INFO Verified hypothesis hypothesis_2_0 with score 0.0
2025-04-14T18:33:09.066947+0200 INFO Verification completed for 3 hypotheses.
2025-04-14T18:33:09.067466+0200 INFO Best verified hypothesis from iteration 1: hypothesis_0_0 (Score: 0.0000)
2025-04-14T18:33:09.067550+0200 INFO Updated overall best hypothesis ID to: hypothesis_0_0
2025-04-14T18:33:09.067605+0200 INFO Selected best hypothesis based on verification ID: hypothesis_0_0 (Verification Score: 0.0000)
2025-04-14T18:33:09.067660+0200 INFO Final selected best hypothesis: ID hypothesis_0_0, Title: 'Epigenetic-MicroRNA Modulation of IL-17 Pathways as a Novel Therapeutic Strategy in Rheumatoid Arthritis', Final Score (best of verification/triage): 0.0000
2025-04-14T18:33:09.069181+0200 INFO Saved final process state to custom_output_dir/2025-04-14-18-28/process_state.json
2025-04-14T18:33:25.286827+0200 INFO Closed event loop.
2025-04-14T18:33:25.287399+0200 INFO Hypothesis generated successfully for ../evaluation/Novel_Therapeutic_Approaches.json
2025-04-14T18:33:25.287575+0200 INFO Saving hypothesis to JSON: custom_output_dir/2025-04-14-18-28/Novel_Therapeutic_Approaches_hypothesis.json
2025-04-14T18:33:25.290142+0200 INFO Saving hypothesis to Markdown: custom_output_dir/2025-04-14-18-28/Novel_Therapeutic_Approaches_hypothesis.md
2025-04-14T18:33:25.291180+0200 INFO Hypothesis saved successfully to custom_output_dir/2025-04-14-18-28
